- Home
- DAWN vs FBRT Comparison
DAWN vs FBRT Comparison
Compare DAWN & FBRT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DAWN
- FBRT
- Stock Information
- Founded
- DAWN 2018
- FBRT 2012
- Country
- DAWN United States
- FBRT United States
- Employees
- DAWN N/A
- FBRT N/A
- Industry
- DAWN Biotechnology: Pharmaceutical Preparations
- FBRT Real Estate Investment Trusts
- Sector
- DAWN Health Care
- FBRT Real Estate
- Exchange
- DAWN Nasdaq
- FBRT Nasdaq
- Market Cap
- DAWN 1.3B
- FBRT 1.1B
- IPO Year
- DAWN 2021
- FBRT 1985
- Fundamental
- Price
- DAWN $12.79
- FBRT $12.69
- Analyst Decision
- DAWN Strong Buy
- FBRT Strong Buy
- Analyst Count
- DAWN 7
- FBRT 6
- Target Price
- DAWN $36.17
- FBRT $15.25
- AVG Volume (30 Days)
- DAWN 1.0M
- FBRT 444.2K
- Earning Date
- DAWN 10-30-2024
- FBRT 02-12-2025
- Dividend Yield
- DAWN N/A
- FBRT 11.21%
- EPS Growth
- DAWN N/A
- FBRT N/A
- EPS
- DAWN N/A
- FBRT 0.81
- Revenue
- DAWN $101,953,000.00
- FBRT $169,684,000.00
- Revenue This Year
- DAWN N/A
- FBRT N/A
- Revenue Next Year
- DAWN $36.10
- FBRT $8.42
- P/E Ratio
- DAWN N/A
- FBRT $15.65
- Revenue Growth
- DAWN N/A
- FBRT N/A
- 52 Week Low
- DAWN $11.94
- FBRT $11.99
- 52 Week High
- DAWN $18.07
- FBRT $14.57
- Technical
- Relative Strength Index (RSI)
- DAWN 39.97
- FBRT 42.45
- Support Level
- DAWN $12.26
- FBRT $12.95
- Resistance Level
- DAWN $12.81
- FBRT $13.31
- Average True Range (ATR)
- DAWN 0.52
- FBRT 0.28
- MACD
- DAWN -0.05
- FBRT -0.05
- Stochastic Oscillator
- DAWN 28.94
- FBRT 37.37
About DAWN Day One Biopharmaceuticals Inc.
Day One Biopharmaceuticals Inc is a clinical-stage biopharmaceutical company. It is dedicated towards developing and commercializing targeted therapies for patients of all ages with genetically defined cancers. Initially, it focuses on clinical development efforts on pediatric patients living with cancer, a vulnerable population that has been underserved in the recent revolution in targeted therapeutics and immuno-oncology. The product candidate, DAY101, is an oral, brain-penetrant, highly-selective type II pan-rapidly accelerated fibrosarcoma, or pan-RAF, kinase inhibitor.
About FBRT Franklin BSP Realty Trust Inc.
Franklin BSP Realty Trust Inc is a private real estate investment trust that originates, acquires, and manages a diversified portfolio of commercial real estate debt, and first mortgage loans. secured by properties located in the United States.